Wikipedia -WSS

Wikipedia

author：focus 2025-10-01 18:23:44 - browse：145

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Do digital therapeutics have a future in medicine?

Wikipedia

WSS

Biden administration opens offers in Medicare drug price negotiations

Vertex non

A $475,000 price tag for a new cancer drug: crazy or meh?

Vertigo drug brings hope for rare neuron disorder, Niemann

Quicker fix for pulse oximeters urged during FDA public meeting

Idaho college killings prosecutors challenge defense's grand jury claims

leisure time

Wikipedia

hotspot

Medicare details structure of new drug price negotiation program

Commercial surrogacy can be ethical, despite pope’s claims

ChatGPT in medicine: STAT answers readers' burning questions

What to know about the judge who will handle the Trump case

Medicare proposal to cover medical devices draws a mixed reaction

Judge sides with young activists in first

Activists slam private health insurers over coverage restrictions

What we need to know about Arena Bioworks

Affirmative action in medical school literally saved lives

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Wikipedia

A $475,000 price tag for a new cancer drug: crazy or meh?

Novo Nordisk touts Wegovy study, but still struggling with supply

Novo Nordisk touts Wegovy study, but still struggling with supply

Megan Rapinoe shares emotional post following US Women's World Cup exit

Surge in Apellis stock fueled by confidence in safety of its eye drug

Timeline: How the deadly wildfires took over Maui day by day

Wikipedia

focus

entertainment

focus